Pulmonx to Participate in September Investor Conferences

Rhea-AI Summary

Pulmonx (NASDAQ:LUNG), a leader in minimally invasive lung disease treatments, has announced its participation in two upcoming investor conferences in September 2025.

The company will participate in a fireside chat at the Wells Fargo Healthcare Conference on September 4 at 1:30 PM PT in Boston, with a webcast available. Additionally, management will attend the Lake Street Best Ideas Growth Conference on September 11 in New York for one-on-one meetings. Investors can access the Wells Fargo fireside chat webcast through Pulmonx's investor relations website.

REDWOOD CITY, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today announced that management will present at the following investor conferences:

Wells Fargo Healthcare Conference
Format: Fireside Chat and 1x1 meetings
Date: Thursday, September 4 at 1:30 pm PT/ 4:30 pm ET
Location: Boston, MA
Webcast Link: Click here

Lake Street Best Ideas Growth (BIG9) Conference
Format: 1x1 meetings
Date: Thursday, September 11
Location: New York, NY

A live and archived webcast of the fireside chat will be available on the “Investors” section of the Pulmonx website at https://investors.pulmonx.com/.

About Pulmonx Corporation
Pulmonx Corporation (Nasdaq: LUNG) is a global leader in minimally invasive treatments for chronic obstructive pulmonary disease (COPD). Pulmonx’s Zephyr^® Endobronchial Valve, Chartis^® Pulmonary Assessment System, LungTraX™ Platform, and StratX^® Lung Analysis Reports are designed to assess and treat patients with severe emphysema/COPD who despite medical management are still profoundly symptomatic. Pulmonx received FDA pre-market approval to commercialize the Zephyr Valve following its designation as a “breakthrough device.” The Zephyr Valve is commercially available in more than 25 countries, is included in global treatment guidelines and is widely considered a standard of care treatment option for improving breathing, activity and quality of life in patients with severe emphysema. For more information on the Zephyr Valves and the company, please visit www.Pulmonx.com.

Pulmonx^®, AeriSeal^®, Chartis^®, StratX^®, and Zephyr^® are registered trademarks and LungTraX™ is a trademark of Pulmonx Corporation.

Investor Contact
Jeremy Feffer
LifeSci Advisors
jfeffer@lifesciadvisors.com

FAQ

When is Pulmonx (LUNG) presenting at the Wells Fargo Healthcare Conference 2025?

Pulmonx will present at the Wells Fargo Healthcare Conference on Thursday, September 4, 2025 at 1:30 PM PT / 4:30 PM ET in Boston, MA.

How can investors access Pulmonx's Wells Fargo Conference presentation?

Investors can access the live and archived webcast of the fireside chat through the Investors section of Pulmonx's website at investors.pulmonx.com.

What type of presentation will Pulmonx give at the Wells Fargo Healthcare Conference?

Pulmonx will participate in a fireside chat format and will also hold one-on-one meetings with investors.

When is Pulmonx participating in the Lake Street BIG9 Conference 2025?

Pulmonx will participate in the Lake Street Best Ideas Growth Conference on Thursday, September 11, 2025 in New York, NY, conducting one-on-one meetings.